The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Abstract
Lymphocyte-specific interferon regulatory factor (LSIRF) (now called IRF4) is a transcription factor expressed only in lymphocytes. Mice deficient in IRF4 showed normal distribution of B and T lymphocyes at 4 to 5 weeks of age but developed progressive generalized lymphadenopathy. IRF4-deficient mice exhibited a profound reduction in serum immunoglobulin concentrations and did not mount detectable antibody responses. T lymphocyte function was also impaired in vivo; these mice could not generate cytotoxic or antitumor responses. Thus, IRF4 is essential for the function and homeostasis of both mature B and mature T lymphocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pip-deficient animals develop normal numbers of B cells (including λ-expressors) which cannot undergo activation”
From Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers (1999) · cites this paper as Mittrucker et al., 1997
In the citing paper
“whereas PIP function is necessary for maturation of B and T lymphocytes (34”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“whereas PIP−/− animals exhibit a block in peripheral maturation of B cells and fail to produce antibodies in response to antigenic stimulation.”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“Similarly, T cells of the mutant animals (PIP−/−) lack proliferative and cytotoxic responses (34”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [34]
In the citing paper
“IRF-4 2 / 2 mice develop progressive generalized lymphadenopathy and have severe defects in B and T lymphocyte function. (65)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [65]
In the citing paper
“IRF-4 2 / 2 mice develop progressive generalized lymphadenopathy and have severe defects in B and T lymphocyte function. (65)”
From Review: ICSBP/IRF-8: Its Regulatory Roles in the Development of Myeloid Cells (2002) · cites this paper as [65]
Citations
Cites
Differential T Cell Costimulatory Requirements in CD28-Deficient Mice
Shahinian, A., Pfeffer, K., Lee, K. P., Kündig, T. M., Kishihara, K., Wakeham, A. C., Kawai, K., Ohashi, P. S., Thompson, C. B., & Mak, T. W. (1993) · Science · doi:10.1126/science.7688139 · Cited by 1,258
Self-citationInterleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A. I., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,079
Requirement for Transcription Factor IRF-1 in NO Synthase Induction in Macrophages
Kamijo, R., Harada, H., Matsuyama, T., Bosland, M. C., Gerecitano, J. F., Shapiro, D., Le, J., Koh, S. I., Kimura, T., Green, S. J., et al. (1994) · Science · doi:10.1126/science.7510419 · Cited by 843
Self-citationTanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491
Self-citationPip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.
Eisenbeis, C. F., Singh, H., & Storb, U. (1995) · Genes & Development · doi:10.1101/gad.9.11.1377 · Cited by 447
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., & Taniguchi, T. (1995) · Nature · doi:10.1038/376596a0 · Cited by 431
Self-citationBetz, A. G., Milstein, C., González‐Fernández, Á., Pannell, R., Larson, T., & Neuberger, M. S. (1994) · Cell · doi:10.1016/0092-8674(94)90316-6 · Cited by 379
An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes
石原, 正. (1997) · Cited by 366
Transitional B cells are the target of negative selection in the B cell compartment.
Carsetti, R., Köhler, G., & Lamers, M. C. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.6.2129 · Cited by 358
Interferon-Induced Antiviral Actions and Their Regulation
Sen, G. C., & Ransohoff, R. M. (1993) · Advances in virus research · doi:10.1016/s0065-3527(08)60083-4 · Cited by 334
Flagged first, then by citations
Research works printed but not linked: 4
- Lamphier M., Taniguchi T., Immunologist 2, 167 (1994);
- Vaughan P. S., et al., ibid. 377, 362 (1995);
- Schmits R., et al., ibid., p. 1415.
- Healthy 5- to 7-week-old mice were used for all experiments. Mice were maintained according to the guidelines of the Canadian Council of Animal Care. H.-W.M. is a recipient of a grant from the Deutsche Forschungsgemeinschaft. The authors thank M. Bachmann G. Boehmelt G. Duncan D. Ferrick C. Furlonger D. Kägi F. Kiefer L. Marengere C. Paige J. Penninger M. Saunders R. Schmits D. Siderovski D. Speiser S. Yoshinaga and P. Waterhouse for providing reagents and for helpful comments.
Cited by
Sorted by citations
Items 101–200 of 583
Inhibition of Pyrimidine Biosynthesis Pathway Suppresses Viral Growth through Innate Immunity
Lucas‐Hourani, M., Dauzonne, D., Jorda, P., Cousin, G., Lupan, A., Helynck, O., Caignard, G., Janvier, G., André-Leroux, G., Khiar, S., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003678 · Cited by 163
Camicia, R., Winkler, H. C., & Hassa, P. O. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0474-2 · Cited by 177
Hodgkin’s Lymphoma: Biology and Treatment Strategies for Primary, Refractory, and Relapsed Disease
Diehl, V., Stein, H., Hummel, M., Zollinger, R., & Connors, J. M. (2003) · Hematology · doi:10.1182/asheducation-2003.1.225 · Cited by 169
TH-17 differentiation: of mice and men
Laurence, A. D. J., & O’Shea, J. J. (2007) · Nature Immunology · doi:10.1038/ni0907-903 · Cited by 168
Muljo, S. A., & Schlissel, M. S. (2002) · Nature Immunology · doi:10.1038/ni870 · Cited by 164
How I treat HIV-associated lymphoma
Dunleavy, K. M., & Wilson, W. H. (2012) · Blood · doi:10.1182/blood-2011-08-373738 · Cited by 165
Giese, N. A., Gabriele, L., Doherty, T. M., Klinman, D. M., Tadesse-Heath, L., Contursi, C., Epstein, S. L., & Morse, H. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1535 · Cited by 160
Sato, M., Taniguchi, T., & Tanaka, N. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00032-0 · Cited by 166
Transcription Factors in Lymphocyte Development— T and B Cells Get Together
Glimcher, L. H., & Singh, H. (1999) · Cell · doi:10.1016/s0092-8674(00)80955-1 · Cited by 157
Transcriptional regulation of follicular T‐helper (Tfh) cells
Liu, X., Nurieva, R., & Dong, C. (2013) · Immunological Reviews · doi:10.1111/imr.12040 · Cited by 161
Fisher, R. C., & Scott, E. W. (1998) · STEM CELLS · doi:10.1002/stem.160025 · Cited by 158
Crystal structure of PU. 1/IRF-4/DNA ternary complex
Escalante, C. R., Brass, A. L., Pongubala, J. M. R., Shatova, E., Shen, L., Singh, H., & Aggarwal, A. K. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00703-7 · Cited by 154
The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation
Carotta, S., Willis, S. N., Hasbold, J., Inouye, M., Pang, S. H. M., Emslie, D., Light, A., Chopin, M., Shi, W., Wang, H., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140425 · Cited by 163
The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation
Gu, X., Nardone, C., Kamitaki, N., Mao, A., Elledge, S. J., & Greenberg, M. E. (2023) · Science · doi:10.1126/science.adh5021 · Cited by 161
Plasma cell differentiation is coupled to division-dependent DNA hypomethylation and gene regulation
Barwick, B. G., Scharer, C. D., Bally, A. P. R., & Boss, J. M. (2016) · Nature Immunology · doi:10.1038/ni.3519 · Cited by 160
The c-Rel transcription factor and B-cell proliferation: a deal with the devil
Gilmore, T. D., Kalaitzidis, D., Liang, M., & Starczynowski, D. T. (2004) · Oncogene · doi:10.1038/sj.onc.1207410 · Cited by 147
Meraro, D., Hashmueli, S., Koren, B., Azriel, A., Oumard, A., Kirchhoff, S., Hauser, H., Nagulapalli, S., Atchison, M. L., & Levi, B.-Z. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6468 · Cited by 147
The diverse roles of IRF4 in late germinal center B‐cell differentiation
Silva, N. S. D., Simonetti, G., Heise, N., & Klein, U. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01113.x · Cited by 154
Honma, K., Udono, H., Kohno, T., Yamamoto, K., Ogawa, A., Takemori, T., Kumatori, A., Suzuki, S., Matsuyama, T., & Yui, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504226102 · Cited by 143
Self-citationAfzali, B., Mitchell, P., Lechler, R. I., John, S., & Lombardi, G. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04038.x · Cited by 141
Vasanthakumar, A., Liao, Y., Teh, P. P., Pascutti, M. F., Oja, A. E., Garnham, A. L., Gloury, R., Tempany, J. C., Sidwell, T., Cuadrado, E., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.068 · Cited by 144
Pham‐Ledard, A., Prochazkova‐Carlotti, M., Laharanne, E., Vergier, B., Jouary, T., Beylot-Barry, M., & Merlio, J. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.314 · Cited by 139
Cattoretti, G., Shaknovich, R., Smith, P. M., Jäck, H., Murty, V. V. V. S., & Alobeid, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6930 · Cited by 134
Kuo, T. C., & Calame, K. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5556 · Cited by 132
The role of interferon regulatory factors in the interferon system and cell growth control
Harada, H., Taniguchi, T., & Tanaka, N. (1998) · Biochimie · doi:10.1016/s0300-9084(99)80017-0 · Cited by 132
Malignant pirates of the immune system
Rui, L., Schmitz, R., Ceribelli, M., & Staudt, L. M. (2011) · Nature Immunology · doi:10.1038/ni.2094 · Cited by 133
Lineage-Specific Modulation of Interleukin 4 Signaling by Interferon Regulatory Factor 4
Gupta, S. K., Jiang, M., Anthony, A., & Pernis, A. B. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1837 · Cited by 132
Mudter, J., Amoussina, L., Schenk, M., Yu, J., Brüstle, A., Weigmann, B., Atreya, R. N., Wirtz, S. J., Becker, C., Hoffman, A. W., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33227 · Cited by 130
Krishnamoorthy, V., Kannanganat, S., Maienschein‐Cline, M., Cook, S. L., Chen, J., Bahroos, N., Sievert, E. P., Corse, E., Chong, A. S., & Sciammas, R. (2017) · Immunity · doi:10.1016/j.immuni.2017.09.001 · Cited by 129
Targeting MYC in multiple myeloma
Jovanović, K., Roche‐Lestienne, C., Ghobrial, I. M., Facon, T. T. F., Quesnel, B., & Manier, S. (2018) · Leukemia · doi:10.1038/s41375-018-0036-x · Cited by 133
Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU. 1 complex
Kanno, Y., Levi, B.-Z., Tamura, T., & Ozato, K. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.770 · Cited by 128
Papavassiliou, A. G., & Musti, A. M. (2020) · Cells · doi:10.3390/cells9112470 · Cited by 124
Conery, A. R., Centore, R. C., Neiss, A., Keller, P. J., Joshi, S., Spillane, K. L., Sandy, P., Hatton, C., Pardo, E., Zawadzke, L. E., et al. (2016) · eLife · doi:10.7554/elife.10483 · Cited by 129
Wang, J., Delabie, J., Aasheim, H., Smeland, E. B., & Myklebost, O. (2002) · BMC Bioinformatics · doi:10.1186/1471-2105-3-36 · Cited by 125
Willis, S. N., Good‐Jacobson, K. L., Curtis, J., Light, A., Tellier, J., Shi, W., Smyth, G. K., Tarlinton, D. M., Belz, G. T., Corcoran, L. M., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303216 · Cited by 124
Understanding the development and function of T follicular helper cells
Nurieva, R., & Chung, Y. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.24 · Cited by 131
Ramos, J. A., Miller, M. A., & Valli, V. E. (2007) · Veterinary Pathology · doi:10.1354/vp.44-6-875 · Cited by 122
Chapter 6 Interleukin 5 in the Link Between the Innate and Acquired Immune Response
Takatsu, K., Kouro, T., & Nagai, Y. (2009) · Advances in immunology · doi:10.1016/s0065-2776(08)01006-7 · Cited by 123
Complex interactions of transcription factors in mediating cytokine biology in T cells
Li, P., Spolski, R. J., Liao, W., & Leonard, W. J. (2014) · Immunological Reviews · doi:10.1111/imr.12199 · Cited by 124
Chartouni, C. E., Schwarzfischer, L., & Rehli, M. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.05.031 · Cited by 125
Langerhans cells are generated by two distinct PU.1-dependent transcriptional networks
Chopin, M., Seillet, C., Chevrier, S., Wu, L., Wang, H., Morse, H. C., Belz, G. T., & Nutt, S. L. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130930 · Cited by 122
Nayar, R., Schutten, E., Bautista, B., Daniels, K. A., Prince, A., Enos, M., Brehm, M. A., Swain, S. L., Welsh, R. M., & Berg, L. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303187 · Cited by 118
Chevrier, S., Emslie, D., Shi, W., Kratina, T., Wellard, C. J., Karnowski, A., Erikçi, E., Smyth, G. K., Chowdhury, K., Tarlinton, D. M., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131831 · Cited by 118
Lehtonen, A., Veckman, V., Nikula, T., Lahesmaa, R., Kinnunen, L., Matikainen, S., & Julkunen, I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6570 · Cited by 120
The KDM3A–KLF2–IRF4 axis maintains myeloma cell survival
Ohguchi, H., Hideshima, T., Bhasin, M., Görgün, G., Santo, L., Cea, M., Samur, M., Mimura, N., Suzuki, R., Tai, Y.-T., et al. (2016) · Nature Communications · doi:10.1038/ncomms10258 · Cited by 116
Regulation of Apoptosis in Myeloid Cells by Interferon Consensus Sequence–Binding Protein
Gabriele, L., Phung, J., Fukumoto, J., Segal, D., Wang, I.-M., Giannakakou, P., Giese, N. A., Ozato, K., & Morse, H. C. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.411 · Cited by 114
Modular Nature of Blimp-1 in the Regulation of Gene Expression during B Cell Maturation
Sciammas, R., & Davis, M. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5427 · Cited by 114
Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo
Ulges, A., Klein, M., Reuter, S., Gerlitzki, B., Hoffmann, M., Grebe, N., Staudt, V., Stergiou, N., Bohn, T., Brühl, T.-J., et al. (2015) · Nature Immunology · doi:10.1038/ni.3083 · Cited by 112
Modulation of T Cell Cytokine Production by Interferon Regulatory Factor-4
Hu, C.-M., Jang, S. Y., Fanzo, J., & Pernis, A. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205895200 · Cited by 113
Interferon regulatory factor 4 and 8 in B-cell development
Lu, R. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.07.006 · Cited by 111
Wies, E., Mori, Y., Hahn, A. S., Kremmer, E., Stürzl, M., Fleckenstein, B., & Neipel, F. (2007) · Blood · doi:10.1182/blood-2007-05-092288 · Cited by 110
Ahn, J. H., Lee, Y., Jeon, C., Lee, S.-J., Lee, B.-H., Choi, K. D., & Bae, Y. (2002) · Blood · doi:10.1182/blood.v100.5.1742.h81702001742_1742_1754 · Cited by 109
Nayar, R., Enos, M., Prince, A., Shin, H., Hemmers, S., Jiang, J., Klein, U., Thomas, C. J., & Berg, L. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205742109 · Cited by 106
Gene Expression Profiling of Diffuse Large B-Cell Lymphoma
Rosenwald, A., & Staudt, L. M. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001623775 · Cited by 105
Moros, A., Rodríguez, V., Saborit-Villarroya, I., Montraveta, A., Balsas, P., Sandy, P., Martı́nez, A., Wiestner, A. U., Normant, E., Campo, E., et al. (2014) · Leukemia · doi:10.1038/leu.2014.106 · Cited by 104
Sundram, U. N., Harvell, J. D., Rouse, R. V., & Natkunam, Y. (2003) · Modern Pathology · doi:10.1097/01.mp.0000081726.49886.cf · Cited by 101
Yeow, W.-S., Au, W.-C., Juang, Y., Fields, C. D., Dent, C. L., Gewert, D. R., & Pitha, P. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6313 · Cited by 98
Afshar‐Sterle, S., Zotos, D., Bernard, N. J., Scherger, A. K., Rödling, L., Alsop, A. E., Walker, J. A., Masson, F., Belz, G. T., Corcoran, L. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3442 · Cited by 105
Different Kinetics of Blimp-1 Induction in B Cell Subsets Revealed by Reporter Gene
Fairfax, K. A., Corcoran, L. M., Pridans, C., Huntington, N. D., Kallies, A., Nutt, S. L., & Tarlinton, D. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4104 · Cited by 100
The Calcineurin Phosphatase Complex Modulates Immunogenic B Cell Responses
Winslow, M. M., Gallo, E. M., Neilson, J. R., & Crabtree, G. R. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.013 · Cited by 100
Eibel, H., Kraus, H., Sic, H., Kienzler, A., & Rizzi, M. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0434-8 · Cited by 123
Jundt, F., Kley, K., Anagnostopoulos, I., Pröbsting, K. S., Greiner, A., Mathas, S., Scheidereit, C., Wirth, T. C., Stein, H., & Dörken, B. (2002) · Blood · doi:10.1182/blood.v99.8.3060 · Cited by 96
Raczkowski, F., Ritter, J., Heesch, K., Schumacher, V., Guralnik, A., Höcker, L., Raifer, H., Klein, M., Bopp, T., Harb, H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309378110 · Cited by 98
Self-citationDonor colonic CD103+ dendritic cells determine the severity of acute graft-versus-host disease
Koyama, M., Cheong, M., Markey, K. A., Gartlan, K. H., Kuns, R. D., Locke, K. R., Lineburg, K. E., Teal, B. E., Leveque, L., Bunting, M. D., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150329 · Cited by 103
Venetz, D., Ponzoni, M., Schiraldi, M., Ferreri, A. J. M., Bertoni, F., Doglioni, C., & Uguccioni, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25236 · Cited by 97
Posttranslational Regulation of IRF-4 Activity by the Immunophilin FKBP52
Mamane, Y., Sharma, S., Petropoulos, L., Lin, R., & Hiscott, J. B. (2000) · Immunity · doi:10.1016/s1074-7613(00)80166-1 · Cited by 95
Li, S., Pal, R., Monaghan, S. A., Schafer, P. H., Ouyang, H., Mapara, M. Y., Galson, D. L., & Lentzsch, S. (2011) · Blood · doi:10.1182/blood-2010-10-314278 · Cited by 94
Transcriptional regulatory cascades controlling plasma cell differentiation
Lin, K., Tunyaplin, C., & Calame, K. L. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00040.x · Cited by 94
Wu, J., Zhang, H., Shi, X., Xiao, X., Fan, Y., Minze, L. J., Wang, J., Ghobrial, R. M., Xia, J., Sciammas, R., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.003 · Cited by 93
CCL17 blockade as a therapy for osteoarthritis pain and disease
Lee, M.-C., Saleh, R., Achuthan, A. A., Fleetwood, A. J., Förster, I., Hamilton, J. A., & Cook, A. D. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1560-9 · Cited by 93
Sidwell, T., Liao, Y., Garnham, A. L., Vasanthakumar, A., Gloury, R., Blume, J., Teh, P. P., Chisanga, D., Thelemann, C., Rivera, F. D. L., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14112-2 · Cited by 98
Swanson, R. V., Gupta, A., Foreman, T. W., Lu, L., Choreño-Parra, J. A., Mbandi, S. K., Rosa, B. A., Akter, S., Das, S., Ahmed, M., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01476-3 · Cited by 94
Gene expression profiling reveals a highly specialized genetic program of plasma cells
Underhill, G. H., George, D., Bremer, E. G., & Kansas, G. S. (2003) · Blood · doi:10.1182/blood-2002-08-2673 · Cited by 93
Monocyte Differentiation to Macrophage Requires Interferon Regulatory Factor 7
Lu, R., & Pitha, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100421200 · Cited by 89
The development of functional B lymphocytes in conditional PU.1 knock-out mice
Polli, M., Dakic, A., Light, A., Wu, L., Tarlinton, D. M., & Nutt, S. L. (2005) · Blood · doi:10.1182/blood-2005-01-0283 · Cited by 89
Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity
Sogkas, G., Atschekzei, F., Adriawan, I. R., Dubrowinskaja, N., Witte, T., & Schmidt, R. E. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00626-z · Cited by 95
Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4
Tominaga, N. (2002) · International Immunology · doi:10.1093/intimm/dxg001 · Cited by 92
Marecki, S., Atchison, M. L., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2713 · Cited by 87
Repression of BCL-6 is required for the formation of human memory B cells in vitro
Kuo, T. C., Shaffer, A. L., Haddad, J., Choi, Y. S., Staudt, L. M., & Calame, K. L. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062104 · Cited by 87
Determining germinal centre B cell fate
Zotos, D., & Tarlinton, D. M. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.04.003 · Cited by 97
IRF4 and BATF are critical for CD8+ T-cell function following infection with LCMV
Grusdat, M., McIlwain, D. R., Xu, H. C., Pozdeev, V. I., Knievel, J., Crome, S. Q., Robert-Tissot, C., Dress, R. J., Pandyra, A. A., Speiser, D. E., et al. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.19 · Cited by 86
Self-citationThe interferon regulatory factors and oncogenesis
Tanaka, N., & Taniguchi, T. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0310 · Cited by 85
Meraro, D., Gleit-Kielmanowicz, M., Hauser, H., & Levi, B.-Z. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6224 · Cited by 105
Interferon Regulatory Factors in Hematopoietic Cell Differentiation and Immune Regulation
Battistini, A. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0030 · Cited by 87
Interferon regulatory factor 1 inactivation in human cancer
Alsamman, K., & El-Masry, O. S. (2018) · Bioscience Reports · doi:10.1042/bsr20171672 · Cited by 86
CCR7 and IRF4-dependent dendritic cells regulate lymphatic collecting vessel permeability
Ivanov, S., Scallan, J. P., Kim, K.-W., Werth, K., Johnson, M. W., Saunders, B. T., Wang, P. L., Kuan, E. L., Straub, A. C., Ouhachi, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84518 · Cited by 81
Low, M. S. Y., Brodie, E. J., Fedele, P. L., Liao, Y., Grigoriadis, G., Strasser, A., Kallies, A., Willis, S. N., Tellier, J., Shi, W., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.097 · Cited by 87
Type I interferons: expression and signalization
Doly, J., Civas, A., Navarro, S., & Uzé, G. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050240 · Cited by 82
Regulating B‐cell activation and survival in response to TLR signals
Gerondakis, S., Grumont, R. J., & Banerjee, A. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100097 · Cited by 84
Banerjee, S., Lu, J. L., Cai, Q., Saha, A., Jha, H. C., Dzeng, R. K., & Robertson, E. S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003314 · Cited by 81
IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis?
Biswas, P. S., Bhagat, G., & Pernis, A. B. (2009) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00864.x · Cited by 84
Distinct regulation of effector and memory T‐cell differentiation
Kallies, A. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.16 · Cited by 76
Interferon Regulatory Factor 4 controls TH1 cell effector function and metabolism
Mahnke, J., Schumacher, V., Ahrens, S., Käding, N., Feldhoff, L., Huber, M., Rupp, J., Raczkowski, F., & Mittrücker, H. (2016) · Scientific Reports · doi:10.1038/srep35521 · Cited by 81
Self-citationIRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma
Ramos, J. C., Ruiz, P., Ratner, L., dos Reis, I. M., Brites, C. R., Pedroso, C., Byrne, G. E., Toomey, N., Andela, V. B., Harhaj, E. W., et al. (2006) · Blood · doi:10.1182/blood-2006-07-036368 · Cited by 81
Targeting IRF4 in autoimmune diseases
Xu, W., Pan, H., Ye, D., & Xu, Y. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.08.011 · Cited by 82
Emslie, D., D’Costa, K., Hasbold, J., Metcalf, D., Takatsu, K., Hodgkin, P. D., & Corcoran, L. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072049 · Cited by 79
Gualco, G., Weiss, L. M., & Bacchi, C. E. (2010) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e3181cf1126 · Cited by 80
MUM1: a step ahead toward the understanding of lymphoma histogenesis
Gaïdano, G., & Carbone, A. (2000) · Leukemia · doi:10.1038/sj.leu.2401748 · Cited by 78
A Two-Step Mechanism for Recruitment of Pip by PU.1
Perkel, J. M., & Atchison, M. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.241 · Cited by 77
PU.1/Interferon Regulatory Factor Interactions; Mechanisms of Transcriptional Regulation
Marecki, S., & Fenton, M. J. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:33:2:127 · Cited by 74
Metadata
- Authors
- Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W.
- Affiliations
- University of Toronto (CA)
- Nagasaki University (JP)
- B. Patterson, Department of Oncologic Pathology, Ontario Cancer Institute, 610 University Avenue, Toronto, Ontario, M5G 2C1, Canada.
- Venue
- Science
- Published
- 1997-01-24
- Volume
- 275
- Issue
- 5299
- Pages
- 540-543
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2022687427
- Cited by
- 583
- References
- 21
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 12 · 2023: 20 · 2022: 23 · 2021: 23 · 2020: 17 · 2019: 15 · 2018: 16 · 2017: 20 · 2016: 15 · 2015: 18 · 2014: 25 · 2013: 32 · 2012: 20
- FWCI
- 8.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- IRF4, transcription factors, B cells, T cells, lymphocyte homeostasis, lymphadenopathy, antibody deficiency, antibody response, cytotoxic T lymphocytes, antitumor immunity
- MeSH terms
- Lymphadenopathy, Interferon Regulatory Factor-4, Animals, Antibody Formation, B-Lymphocytes, Cell Differentiation, Cells, Cultured, Homeostasis, Mice, Inbred BALB C, T-Lymphocytes, Cytotoxic, Transcription, Genetic, Mice, SCID, Mice, Knockout, Cell Proliferation, Interferon Regulatory Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review